La Jolla Pharmaceutical Overview

La Jolla Pharmaceutical EBIT

EBIT (Earnings Before Interest and Taxes) analysis for LJPC.

Quarterly EBIT

$4.85M

↓ 24.32% YoY

As of Jun 30, 2022

Annual EBIT (TTM)

$13.97M

↑ 4.35% YoY

Trailing 12 months ending Jun 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin